Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 26 |
BlackRock Advisors
Wilmington,
Delaware
| $313M | +$8.67M | 25 | 0.34% | Increased |
|
| 27 |
JP Morgan Chase
New York
| $294M | -$5.75M | 15 | 0.08% | Reduced |
|
| 28 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $274M | +$10.2M | 21 | 0.29% | Increased |
|
| 29 |
Bank of New York Mellon
New York
| $273M | -$1.28M | 28 | 0.08% | Reduced |
|
| 30 |
Manning & Napier Advisors
Fairport,
New York
| $256M | +$148M | 1 | 1.37% | Increased |
|
| 31 |
Renaissance Technologies
New York
| $254M | +$35.5M | 14 | 0.61% | Increased |
|
| 32 |
Parnassus Investments
San Francisco,
California
| $243M | +$11.1M | 1 | 1.79% | Increased |
|
| 33 |
Ameriprise
Minneapolis,
Minnesota
| $240M | +$4.33M | 9 | 0.15% | Increased |
|
| 34 |
Jennison Associates
New York
| $240M | -$27.9M | 11 | 0.25% | Reduced |
|
| 35 |
Mawer Investment Management
Calgary,
Alberta, Canada
| $231M | +$37.6M | 1 | 3.16% | Increased |
|
| 36 |
Goldman Sachs
New York
| $230M | +$34.4M | 22 | 0.08% | Increased |
|
| 37 |
Lazard Asset Management
New York
| $228M | +$9.43M | 8 | 0.54% | Increased |
|
| 38 |
First Trust Advisors
Wheaton,
Illinois
| $226M | +$68.8M | 6 | 0.66% | Increased |
|
| 39 |
Capital World Investors
Los Angeles,
California
| $225M | +$2.43M | 4 | 0.07% | Increased |
|
| 40 |
BBA
Baker Bros. Advisors
New York
| $221M | +$66.8M | 10 | 2.04% | Increased |
|
| 41 |
OrbiMed
New York
| $220M | -$11.4M | 7 | 2.22% | Reduced |
|
| 42 |
ClearBridge Investments
New York
| $219M | -$1.76M | 4 | 0.26% | Reduced |
|
| 43 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
| $216M | -$4.94M | 2 | 22.3% | Reduced |
|
| 44 |
Janus Henderson Investors US
Denver,
Colorado
| $213M | +$21.5M | 8 | 0.19% | Increased |
|
| 45 |
VAM
Visium Asset Management
New York
| $210M | +$21.8M | 9 | 2.87% | Increased |
|
| 46 |
UBS AM
Chicago,
Illinois
| $205M | +$16.8M | 13 | 0.23% | Increased |
|
| 47 |
EARNEST Partners
Atlanta,
Georgia
| $205M | +$949K | 1 | 2.02% | Increased |
|
| 48 |
Columbia Wanger Asset Management
Chicago,
Illinois
| $189M | -$171M | 2 | 1.51% | Reduced |
|
| 49 |
Dimensional Fund Advisors
Austin,
Texas
| $183M | +$13.8M | 8 | 0.12% | Increased |
|
| 50 |
Millennium Management
New York
| $178M | +$14.7M | 22 | 0.34% | Increased |
|